These Seattle tech companies have big plans on the horizon after raising venture capital funding last month. Seattle’s five largest tech funding rounds in October totaled a collective $133 million, hailing from an array of companies working in the productivity, fintech, biotech and software sectors. Read on to see what these companies have planned for November and beyond.
Largest Seattle Tech Funding Rounds, October 2022
- Viome Life Sciences
- Diagrid
- Lassen Peak
- Xembly
- Center
#4 (tied). Center: $15 million, October 26
Center helps companies track, manage and automate their employee’s expenses in real time. The Bellevue-based startup’s Series B round brings its total venture capital raised to more than $100 million. The fresh capital will go toward growing its team and building out its product line.
#4 (tied). Xembly: $15 million, October 4
Led by Norwest Venture Partners, the $15 million Series A will help the company scale its customer base and elevate its machine learning and natural language processing capabilities. Xembly is a conversational artificial intelligence solution that increases productivity in the workplace by automating tasks like scheduling, creating to-do lists, providing meeting feedback and more.
#3. Lassen Peak: $16 million, October 13
Lassen Peak is developing the first fully-integrated handheld radar system that can help law enforcement officials and military members detect concealed weapons. The Bellevue-based company plans to expand its product offering to aircraft pilots following its latest $16 million Series A and strategic A1 rounds.
#2. Diagrid: $20 million, October 12
Having recently emerged from stealth, Diagrid is working to increase productivity for developers by providing them with tools and APIs to build cloud-native applications. To date, the company has raised $24.2 million made up of a $20 million Series A round and a $4.2 million seed round. A portion of the funding will go toward growing Diagrid’s engineering, customer support, developer advocacy and sales teams.
#1. Viome Life Sciences: $67 million, October 15
Aiming to help people live longer, healthier lives, Viome Life Sciences pulled in a $67 million Series C round that brought its total capital raised to more than $150 million. The Bellevue-based company offers a digital health platform that uses mRNA tech and artificial intelligence-backed solutions to fuel users’ nutrition and health. Viome also has a biotech side that addresses and aims to prevent chronic diseases. The company plans to offer new products, such as an Oral Health Intelligence Test, following its latest capital raise.
